A new, lower price for a drug to treat a rarer form of multiple sclerosis in adults has paved the way for its approval by NICE
Shared Learning Award 2019 finalist
Shared Learning Award 2019 finalist
Shared Learning Award 2019 winner
NICE’s new guideline is the first to offer comprehensive information on neurological conditions to help non-specialist healthcare professionals to identify people who should be referred for specialist assessment and care.
HealthTech Connect, a new online resource provided by NICE to help identify and support new health technologies as they move from inception to adoption in the UK health and care system was formally launched today (29 April).
All women should be able to access both medical and surgical procedures to terminate their pregnancy, says NICE in draft guidance.
People with asthma will be helped to choose the inhaler that is best for them, and best for the environment, by a new patient decision aid from NICE
Dr David Halpern, What Works national adviser, discusses how NICE has inspired evidence-based decision making across the public sector
Mike Williams, senior evaluator, NSPCC, describes why assessment of children at risk needs to be more adaptive
A promising new lung cancer treatment will be available on the NHS through the Cancer Drugs Fund, thanks to a new NICE recommendation.
NICE has today (28 March) published a summary for healthcare professionals bringing together all its recommendations and other safety advice on the drug valproate.
NICE is embarking on an ambitious multi-year programme that will review the way we produce and present guidance and advice
Organisation was founded in April 1999 to improve outcome for health service users
NICE has today (28 August 2019) published its updated guideline on the diagnosis and treatment of high blood pressure (hypertension).
Multimorbidity needs a new model of treatment, the authors explain why and how
Hundreds more people with severe to profound deafness will be eligible for cochlear implants each year, due to updated NICE guidance
Cathy Rodway, Programme Manager at the National Confidential Inquiry into Suicide and Safety in Mental Health (NCISH), tells us why it is important to support the review of self-harm services in local areas
The updated quality standard highlights that authorities should assess planning applications and consider how the effects of traffic-related air pollution may affect local communities.
NICE has published draft guidance which confirms its earlier decision not to recommend cerliponase alfa (also called Brineura and made by Biomarin) for children with Batten disease – a very rare inherited condition affecting between 1 and 6 babies each year in the UK.
More than 60 entries received from organisations across the country which highlight how they put NICE guidance into practice
Karen O’Brien, CDAO leading on Greater Manchester Strategy Implementation Plan, Greater Manchester Health & Social Care Partnership (HSCP), discusses medicines optimisation and the resources available on the NICE website
NICE has published final draft guidance recommending pertuzumab (Perjeta, Roche) for treating early HER2-positive breast cancer in people whose disease has spread to their lymph nodes.
The NICE Scientific Advice team, working with the Science Policy and Research team at NICE, has provided its first piece of advice on the design of a patient preference study.
These two guidelines set out an antimicrobial prescribing strategy that aims to optimise antibiotic use and reduce antibiotic resistance.
Angelica experienced abuse aged 12. She shares her story and talks about her role in developing NICE guidance.
NICE is updating its guideline on Alcohol interventions in secondary and further education.
NICE and the Canadian Agency for Drugs and Technology in Health (CADTH) have launched a new collaboration to offer parallel scientific advice to the life sciences industry.
Adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) will be able to access another revolutionary chimeric antigen receptor T-Cell (CAR T-cell) therapy through the Cancer Drugs Fund.
NICE has announced a collaboration with the body which represents life sciences organisations in the UK.
Children and young people can be offered digital cognitive behavioural therapy (digital CBT, also known as computer CBT) as a first-line treatment for mild depression.
Thousands of people will benefit as NICE recommends venetoclax with rituximab for adults with relapsed or refractory chronic lymphocytic leukaemia.
Procedure will extend the life of a donor liver by double the length of time compared to now
NICE has published its guideline on the care and support needs of adults with cerebral palsy.
Annabel Dawson, lay reviewer for National Institute for Health Research discussed the importance of end of life planning
NICE has said that a new drug for preventing migraine is not a cost effective use of NHS resources, in draft guidance published today.
Physical inactivity is responsible for one in six deaths and is believed to cost the UK £7.4 billion each year, including £900 million to the NHS
Another potentially life-changing treatment should be available to people with a severe form of asthma, NICE says.
Explore data about our technology appraisal guidance. Find out about the decisions we make and our ways of working.
NICE has recommended the scan as a first-line investigation for people with suspected clinically localised prostate cancer.
NICE has published final draft guidance recommending a breakthrough cancer treatment, called CAR T-cell therapy, for adults with certain types of non-Hodgkin lymphoma.
Up to 400 patients each year are set to benefit from the procedure being made available more widely
Healthcare professionals should consider the risk of antimicrobial resistance when deciding whether antibiotics are needed for treating or preventing a flare up of symptoms of chronic obstructive pulmonary disease (COPD).
Jane Gorringe, maternity engagement project manager at Tamba discusses how babies’ lives can be saved if maternity units adhere to NICE guidance on multiple pregnancies.
Approving regorafenib is a "welcome step forward" for those people who are eligible
Meindert Boysen explains how NICE is helping to get transformative healthcare technologies to patients quicker
Patients with acute ischaemic stroke should be offered a procedure to remove the blood clot up to 24 hours after the onset of symptoms.
Hayley Clark, senior business development manager, NSPCC, outlines how NICE and the NSPCC support mental health services tailored to children’s needs
Thousands of lung cancer patients are now eligible for a new life-extending treatment through the Cancer Drugs Fund (CDF).
Sarah Fishburn, quality improvement for Thames Valley Strategic Clinical Network, discusses how postnatal mental health care can be improved